CVC Capital Partners to acquire immunotherapy business Therakos from Mallinckrodt for $925m
The transaction is expected to close in the fourth quarter of 2024.
5 August 2024•1 min read
The transaction is expected to close in the fourth quarter of 2024.
O2 Investment Partners exits Xobee Networks via sale to Sole Source-backed Brite
7 minutes ago · 1 min read
Carlyle and PAI Partners agree to sell Theramex to Cinven
2 hours ago · 1 min read
Hg agrees to back new European AI transformation firm alongside Anthropic
2 hours ago · 1 min read
KKR-backed CIRCOR agrees to acquire Italian pump maker Green Silence Group
3 hours ago · 1 min read
Benford Capital-backed RM Young acquires rain sensor maker Texas Electronics
3 hours ago · 1 min read
Nexus Capital Management acquires Coldwater Creek parent from Newtimes Group
3 hours ago · 1 min read
Platinum Equity acquires Warren Valve from Allied Group in carve-out deal
3 hours ago · 2 mins read
